Newsbenzinga
Reported Earlier, Parabilis Medicines Prices Upsized Initial Public Offering Of 33.5M Shares At $20.00, Raising $670M Plus $75M Concurrent Regeneron Private Placement
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…